Ability of Mosapride to Bind to 5-HT₄ Receptor in the Human Stomach

Abstract

Ability of mosapride, a gastrokinetic agent, to bind to 5-HT₄ receptor was examined in the stomach of human and guinea pig by in vitro receptor autoradiography. [¹²⁵I]SB207710 binding sites were detected in the muscle layer including the myenteric plexus of the stomach from both humans and guinea pigs, although the binding was observed more clearly and densely in the stomach of guinea pigs than humans. Mosapride as well as SB204070 inhibited the binding of [¹²⁵I]SB207710. Thus, mosapride possesses the ability to bind to 5-HT₄ receptors of human stomach and may modulate the motility, as in the case of guinea pig stomach.